Cargando…
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727238/ https://www.ncbi.nlm.nih.gov/pubmed/34983951 http://dx.doi.org/10.1038/s41423-021-00811-8 |
_version_ | 1784626477303595008 |
---|---|
author | Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Winkler, Martin S. Lier, Martin Schulz, Sebastian Jäck, Hans-Martin Pöhlmann, Stefan Hoffmann, Markus |
author_facet | Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Winkler, Martin S. Lier, Martin Schulz, Sebastian Jäck, Hans-Martin Pöhlmann, Stefan Hoffmann, Markus |
author_sort | Arora, Prerna |
collection | PubMed |
description | Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circulating early in the pandemic, and mutations in the viral spike (S) protein are considered of particular relevance since the S protein mediates host cell entry and constitutes the key target of the neutralizing antibody response. As a consequence, mutations in the S protein may increase SARS-CoV-2 infectivity and enable its evasion of neutralizing antibodies. Furthermore, mutations in the S protein can modulate viral transmissibility and pathogenicity. |
format | Online Article Text |
id | pubmed-8727238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87272382022-01-05 No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Winkler, Martin S. Lier, Martin Schulz, Sebastian Jäck, Hans-Martin Pöhlmann, Stefan Hoffmann, Markus Cell Mol Immunol Correspondence Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circulating early in the pandemic, and mutations in the viral spike (S) protein are considered of particular relevance since the S protein mediates host cell entry and constitutes the key target of the neutralizing antibody response. As a consequence, mutations in the S protein may increase SARS-CoV-2 infectivity and enable its evasion of neutralizing antibodies. Furthermore, mutations in the S protein can modulate viral transmissibility and pathogenicity. Nature Publishing Group UK 2022-01-05 2022-03 /pmc/articles/PMC8727238/ /pubmed/34983951 http://dx.doi.org/10.1038/s41423-021-00811-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Winkler, Martin S. Lier, Martin Schulz, Sebastian Jäck, Hans-Martin Pöhlmann, Stefan Hoffmann, Markus No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title | No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title_full | No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title_fullStr | No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title_full_unstemmed | No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title_short | No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 |
title_sort | no evidence for increased cell entry or antibody evasion by delta sublineage ay.4.2 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727238/ https://www.ncbi.nlm.nih.gov/pubmed/34983951 http://dx.doi.org/10.1038/s41423-021-00811-8 |
work_keys_str_mv | AT aroraprerna noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT kempfamy noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT nehlmeieringa noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT graichenluise noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT winklermartins noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT liermartin noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT schulzsebastian noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT jackhansmartin noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT pohlmannstefan noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 AT hoffmannmarkus noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42 |